NM_024675.4(PALB2):c.3105_3113+28dup AND Hereditary cancer-predisposing syndrome

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Dec 8, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002326017.2

Allele description [Variation Report for NM_024675.4(PALB2):c.3105_3113+28dup]

NM_024675.4(PALB2):c.3105_3113+28dup

Gene:

PALB2:partner and localizer of BRCA2 [Gene - OMIM - HGNC]

Variant type:

Duplication

Cytogenetic location:

16p12.2

Genomic location:

Preferred name:

NM_024675.4(PALB2):c.3105_3113+28dup

HGVS:

NC_000016.10:g.23621334_23621370dup
NG_007406.1:g.24988_25024dup
NM_024675.4:c.3105_3113+28dupMANE SELECT
LRG_308t1:c.3105_3113+28dup
LRG_308:g.24988_25024dup
NC_000016.9:g.23632655_23632691dup
NM_024675.3:c.3105_3113+28dupTGTTATTTGGTAAGCTTTCCCTCTAGGTCCTCAGTTC

Molecular consequence:

NM_024675.4:c.3105_3113+28dup - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:: Hereditary cancer-predisposing syndrome
Synonyms:: Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Clear Turn Off Turn On

Vanacampus margaritifer isolate Vanmar0483 16S ribosomal RNA gene, partial seque...
Vanacampus margaritifer isolate Vanmar0483 16S ribosomal RNA gene, partial sequence; mitochondrial
gi|1143649820|gb|KY065603.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002605933	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Dec 8, 2021)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002605933

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Dec 8, 2021)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV002605933.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The c.3105_3113+28dup37 variant results from a duplication of 37 nucleotide(s) within and after coding exon 10 of the PALB2 gene. This nucleotide region is not well conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration does not have any significant effect on the native donor splice site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 1, 2024

ClinVar

Relating variation to medicine